Hemp contains over 480 active compounds, 80 of which are found exclusively in cannabis. That's so many different variables acting on the body, and it's also part of the reason why there's constantly new research being published highlighting new discoveries about cannabis. The 80 compounds present in cannabis alone are cannabinoids. They interact with receptors in the body to produce effects on the nervous system and brain. The following is a brief presentation of the 8 main cannabinoids found in cannabis.
CBD
Cannabidiol, or CBD for short, is the second most abundant substance in cannabis. It has important applications in the field of medicine, and is the compound sought by many medical consumers. It is a non-psychoactive compound thought to regulate and reduce the effects of THC. This means that strains with high THC and CBD contents produce a "clear head" rather than a "foggy" effect, and strains with high brain activity contain little CBD. CBD has a long list of medical properties, including relief from chronic pain, inflammation, migraines, arthritis, spasms, epilepsy and schizophrenia. CBD has also been shown to have anti-cancer properties, and new properties are continually being discovered as research advances.
THC
It's the best-known and most abundant cannabinoid in cannabis, the exact name being delta-9-tetrahydrocannibinol. This cannabinoid is responsible for the main psychoactive effect experienced when consuming cannabis, stimulating parts of the brain and causing the release of dopamine, resulting in a feeling of euphoria and well-being. THC also has analgesic effects, relieving symptoms of pain and inflammation. Combined, these effects produce a great sense of relaxation.
CBN
Cannabinol, or CBN for short, is an analgesic created by the breakdown of THC through oxidation. It is slightly psychoactive and is found in small quantities in fresh cannabis plants. It can be kept to minimum levels by storing harvested weed in a cool, dry place. The effects of THC are generally preferred to those of CBN: CBN is not as potent as THC and can cause dizziness in high concentrations. It is also known to reduce anxiety and relieve pressure behind the eyes.
CBG
CBG, also known as cannabigerol, is an active cannabis compound best known for its anti-bacterial properties. However, recent research has found that, although traditionally thought not to be predominant in most cannabis strains, CBG is likely to be the "template" or "stem cell" for THC and CBD. This means that THC and CBD start out as CBG. CBG has also been shown to inhibit GABA uptake, resulting in a relaxation effect normally associated with CBD. These findings have prompted further research into cannabinoids, pointing to possible wider implications.
THCV
Tetrahydrocannabivarin, or THCV for short, is a cannabinoid that moderates the intensity of THC's psychoactive effects. Ongoing research on THCV suggests that it can be used to treat metabolic disorders, and may therefore act as an appetite suppressant.
CBC
Cannabichromene, or CBC for short, is said to have anti-inflammatory and analgesic effects, although little medical research has been carried out on this cannabinoid. Recent studies suggest that it may play a potential role in brain cell regeneration.
THCA
THCA is the acid form of THC. It is the raw form in which THC is present in fresh cannabis plants. When cannabis is heated, THCA is transformed into THC. It is not, however, considered an active ingredient.
CBDA
Like THCA, CBDA is the acid form of CBD. Currently, it is thought to have antiemetic (anti-nausea) effects and may help fight cancer. However, more research into its medical benefits is still needed.
All these data are the property of SWISS MEDICAL CANNABIS SA. It is protected by the 91/250/EEC and 96/9/EC directives, which grant copyright protection to computer programs and databases respectively. SWISS MEDICAL CANNABIS SA. reserves the right to take legal action against any copy or reproduction of our information. We also reserve the right to bring an action for damages, in accordance with Article L. 331-1-3 of the CPI, which states that "to determine the damages, the court shall take into consideration the negative economic consequences, including loss of earnings, suffered by the injured party, the profits made by the author of the infringement of rights and the moral prejudice caused to the owner of these rights as a result of the infringement.



Ping back: Dosages and advice on taking CBD | Swiss Medical Cannabis SA
Ping back: CBD recognized as a mainstream product by the World Health Organization | Swiss Medical Cannabis SA
Ping back: National Cancer Institute approves use of cannabinoids | Swiss Medical Cannabis SA
Ping back: The endocannabinoid system is essential to your body's balance | Swiss Medical Cannabis SA